BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:32 PM
 | 
Jun 18, 2010
 |  BC Extra  |  Clinical News

Tanezumab meets osteoarthritis endpoints

Pfizer Inc. (NYSE:PFE) said IV tanezumab every eight weeks met the co-primary endpoints of significantly improving mean WOMAC Pain and Physical...

Read the full 94 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >